FDA approves Neurogene's Rett syndrome gene therapy registrational trial design

1 week ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. FDA approves Neurogene's Rett syndrome gene therapy registrational trial design

Related

Carnival Corporation set to snap six days of gains as shares trade in red

Carnival Corporation set to snap six days of gains as shares...

6 minutes ago 0
Lemonade launches car insurance product in Indiana

Lemonade launches car insurance product in Indiana

12 minutes ago 0
GE Vernova started at Buy at UBS, as earnings seen lifted by AI-driven power demand

GE Vernova started at Buy at UBS, as earnings seen lifted by...

22 minutes ago 0
Blue Owl Technology Finance initiated with Buy at Truist Securities

Blue Owl Technology Finance initiated with Buy at Truist Sec...

30 minutes ago 0
Forget a ‘shadow’ Fed chair, here’s how the central bank could have two different leaders at once

Forget a ‘shadow’ Fed chair, here’s how the central bank cou...

37 minutes ago 0
Stocks tumble after Trump announces steep tariffs on imports from Japan, Korea, and 5 other countries

Stocks tumble after Trump announces steep tariffs on imports...

39 minutes ago 0
Robinhood under scrutiny from Lithuanian central bank over tokenized stocks - report

Robinhood under scrutiny from Lithuanian central bank over t...

42 minutes ago 0
Trump administration sued by Planned Parenthood over Medicaid cuts

Trump administration sued by Planned Parenthood over Medicai...

49 minutes ago 0
Shoals Technologies raised at Jefferies as Trump's bill seen sparking short-term solar activity

Shoals Technologies raised at Jefferies as Trump's bill seen...

51 minutes ago 0
Pony AI is expected by BofA to benefit from new collaborations

Pony AI is expected by BofA to benefit from new collaboratio...

1 hour ago 0
Bill Gates was right to defend USAID amid Elon Musk’s attacks—take it from someone who experienced its impact

Bill Gates was right to defend USAID amid Elon Musk’s attack...

1 hour ago 0
CoreWeave's acquisition increases data center footprint: analysts

CoreWeave's acquisition increases data center footprint: ana...

1 hour ago 0
Southwest Airlines dips after notching six straight sessions of gains

Southwest Airlines dips after notching six straight sessions...

1 hour ago 0
MP Materials downgraded at Jefferies on limited upside after rally

MP Materials downgraded at Jefferies on limited upside after...

1 hour ago 0
Tariffs push U.S. tax rates to post-WWII highs, yet USD paradoxically strengthens – Seymour

Tariffs push U.S. tax rates to post-WWII highs, yet USD para...

1 hour ago 0
SA analyst upgrades/downgrades: GOOS, ANET, QQQ, NET

SA analyst upgrades/downgrades: GOOS, ANET, QQQ, NET

1 hour ago 0
Blackstone considers joint bid for French telecom firm SFR - report

Blackstone considers joint bid for French telecom firm SFR -...

2 hours ago 0
Geely rolls into Italy as its international expansion continues

Geely rolls into Italy as its international expansion contin...

2 hours ago 0
Trump slaps 25% tariffs on Japan and South Korea—and Wall Street stumbles

Trump slaps 25% tariffs on Japan and South Korea—and Wall St...

2 hours ago 0
Fannie Mae housing sentiment survey declines in June

Fannie Mae housing sentiment survey declines in June

2 hours ago 0

Trending

1. oneplus nord 5
2. china
3. nico hülkenberg podium
4. porn star death news
5. panchayat web series
6. akshaye khanna
7. sourav ganguly
8. uefa european women's championship
9. iga świątek
10. portugal vs italy

Popular

Re: No shortage of bombs, but scarcity of everything to starve Gazans by Israel as war weapon: Palestine

Re: No shortage of bombs, but scarcity of everything to star...

2 weeks ago 9
TechCrunch Mobility: The state of EV sales and Rivian secures the next $1B from VW

TechCrunch Mobility: The state of EV sales and Rivian secure...

3 days ago 6
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved